2021/01/18 00:31 Vincent Racaniello (left), Peter Daszak (right). (YouTube, TWiV 615 screenshot) Vincent Racaniello (left), Peter Daszak (right). (YouTube, TWiV 615 screenshot) TAIPEI (Taiwan News) Video taken just days before the start of the coronavirus pandemic shows a current World Health Organization (WHO) inspector discuss the testing of modified coronaviruses on human cells and humanized mice in the Wuhan Institute of Virology (WIV), just weeks before the first cases of COVID-19 were announced in the city of Wuhan itself. In a video that was originally taken on Dec. 9, 2019, three weeks before the Wuhan Municipal Health Commission announced an outbreak of a new form of pneumonia, virologist Vincent Racaniello interviewed British zoologist and president of EcoHealth Alliance Peter Daszak about his work at the nonprofit to protect the world from the emergence of new diseases and predict pandemics. Since 2014, Daszak s o
Reply
The study the largest of its kind examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives. (Shutterstock)
LOS ANGELES, CA An international research team co-led by a UCLA Fielding School of Public Health professor found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications.
The study the largest of its kind examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives, according to Dr. Marc Suchard, a professor of biostatistics at the UCLA Fielding School.
E-Mail
Targeted neuromodulation tailored to individual patients distinctive symptoms is an increasingly common way of correcting misfiring brain circuits in people with epilepsy or Parkinson s disease. Now, scientists at UC San Francisco s Dolby Family Center for Mood Disorders have demonstrated a novel personalized neuromodulation approach that at least in one patient was able to provide relief from symptoms of severe treatment-resistant depression within minutes.
The approach is being developed specifically as a potential treatment for the significant fraction of people with debilitating depression who do not respond to existing therapies and are at high risk of suicide. The brain, like the heart, is an electrical organ, and there is a growing acceptance in the field that the faulty brain networks that cause depression just like epilepsy or Parkinson s disease could be shifted into a healthier state by targeted stimulation, said Katherine Scangos, MD, PhD, an assist
Assessing the importance of interleukin-6 in COVID-19 – Authors reply thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.